During treatment with C1-INH (SC) (40 IU/kg and 60 IU/kg), the median number of HAE attacks per month was 0.10 in female subjects overall, with a 96% median reduction in attacks relative to the pre-study period (Table 3). This evidence concerns the gene SERPING1 and hereditary angioedema.